GIC Invests $85M In Chinese Biomedicine Firm Bloomage

This Data Is Locked!

This area is available only to Subscribers.

Singapore’s sovereign wealth fund GIC Private Limited has agreed to invest HK$659 million (US$85 million) into Hong Kong-listed Chinese biomedicine firm Bloomage BioTechnology Corporation Limited,... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?